Exo-Top

Exo-Top

Israeli biotech startup developing innovative platform for treatment of nervous system diseases

The company is developing treatment for full or partial reversal of paralysis and improving the lives of patients following spinal cord injury using bio-guided exosomes (membrane-bound extracellular vesicles) loaded with modified small interfering RNA (siRNA) sequences. NurExone’s technology is being used to develop treatment of various conditions, including spinal cord

Read More »
January 17, 2023

United States Patent Office Allows Patent to Exosome Biomedical Company NurExone

The Patent discloses and claims groundbreaking inventions and methods in exosome technology, such as the pharmaceutical compositions comprising extracellular vesicles including exosomes, loaded with an exogenous inhibitor of phosphatase and tensin homolog (PTEN) inhibitor as well as a method for treating neuronal injury or damage, including intranasal administration. Read More

Read More »
January 17, 2023

Set layout popup